Flaskworks

Flaskworks is improving the production of immunotherapy and dendritic cell vaccines. The Flaskworks system is also expected to significantly reduce production costs: transforming "open" steps in the manufacturing process into "closed" steps, where products in the manufacturing kit are not exposed to the air, thus eliminating the need to build and operate extremely expensive cleanroom suites for these processes and removing the requirement for personnel to wear sterile lab suits. This will greatly reduce the production costs of DCVax-L.